Our evidence is long term and predictive—NOT snapshot
Statista 2024 https://www.statista.com/topics/1764/global-pharmaceutical-industry/#dossier-chapter3 JAY-HOCH
The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The market has experienced significant growth during the past two decades, and totaled 1.48 trillion U.S. dollars in 2022. Top pharmaceutical company The pharma industry is composed of some major multinational companies. Based on prescription drug sales, U.S. company Pfizer has been among the for many years. The company, which has its global headquarters in New York City, generated of more than 100 billion U.S. dollars in 2022. However, back in 2020, the company saw a heavy drop in revenues after the spin-off of its Upjohn generics business. Other top global players from the United States include Johnson & Johnson, Merck & Co., and . Pharma industry by country Many of the leading pharma companies come from the United States, and, therefore, it is no surprise that the country has the . China has become one of the main players in the industry, although currently fighting with receding growth rates as in many other sectors. Among emerging markets, was very strong in Brazil during 2022. However, show that the established markets of North America and Europe will still be leading the way in the foreseeable future. Some of the biggest European companies are Novartis, Roche, AstraZeneca, and . How much do companies spend on R&D? More than any other industry, the pharmaceutical sector is highly dependent on , with companies investing around 20 percent or more of their sales revenues in R&D projects. This at companies that specialize in research and generate low sales. The discovery of new drugs is vital for the continued growth of pharma companies, and sales of new branded drugs can provide . However, the loss of patent protection can have serious consequences, and competition from generic drugs is a major challenge for companies. The expiration of a product patent can result in a significant reduction in revenues, as experienced by .